Explaining the role of Mounjaro for Type 2 Diabetes
Mounjaro (Tirzepatide): A Novel Approach for Type 2 Diabetes Management As a pharmacy doct…
Anticoagulation Guide for Managing PE and DVT in Critical Care
Overview As a critical care pharmacist, you'll often need to decide whether to sta…
Optimizing Gout Flare Management: Key Approaches for Pharmacists
Overview As a clinical pharmacist, aim to optimize gouty flare management to relieve p…
Management Strategies for Hypertensive Nephropathy in CKD Patients
Overview As a clinical pharmacist, effective BP management in CKD is essential to slow …
Cranberry Products for UTI Prevention: What Pharmacists Need to Know
Overview Cranberry products have been used for decades to prevent urinary tract infe…
Debunking Hyperkalemia Myths: What Clinicians Need to Know
Introduction to hyperkalemia Hyperkalemia is a life-threatening electrolyte disturbanc…
Don't use DIABETES as a CV risk equivalent
As a pharmacy doctor, you will see more consensus on using statins for diabetes patients.…
Do all ICU patients need Stress Ulcer Prophylaxis?
Introduction Patients who are admitted to ICU may suffer from Stress Ulceration, …
Erythropoietin (EPO) dosing in anemia of CKD
Erythropoiesis-stimulating agents (ESAs) like erythropoietin (EPO) are integral for mana…
Resmetirom for Nonalcoholic Steatohepatitis (NASH)
Introducing resmetirom for NASH Resmetirom ( Rezdiffra ) is anticipated to be the fir…